Inbal A, Yee V C, Kornbrot N, Zivelin A, Brenner B, Seligsohn U
Department of Hematology, Sheba Medical Center, Tel-Hashomer, Israel.
Thromb Haemost. 1997 Jun;77(6):1062-7.
In this report we describe the molecular basis of FXIII a-subunit deficiency in three unrelated Palestinian Arab families. In three patients representing each family two substitutions were identified in exon 14 on both alleles: C to G change resulting in a Gln651Glu substitution (a previously described polymorphism) and a T to C transition causing Leu660Pro substitution. The latter is a new mutation which creates a restriction site for FnuDII enzyme. Restriction analysis performed in members of the three families clearly distinguished between severely affected patients, obligate carriers and unaffected subjects. A population survey failed to detect the mutation among 250 Jewish individuals but did detect two heterozygotes among 300 Arabs suggesting a 0.0033 frequency for the Pro660 allele in this population. In two out of the three families the Pro660 allele was linked to allele 5 of the 5' short tandem repeat polymorphism within the FXIII a-subunit gene suggesting that the mutation might have occurred at least twice. cDNA obtained from mRNA isolated from patients' platelets and monocytes appeared similar in size to that of normal control indicating that the Leu660Pro mutation does not affect mRNA synthesis. Computer modeling based on cristallographic studies of the a-subunit of factor XIII predicted that the mutant protein is expected to misfold into a structure which is either unstable or susceptible to degradation.
在本报告中,我们描述了三个不相关的巴勒斯坦阿拉伯家庭中因子 XIII a 亚基缺乏症的分子基础。在代表每个家庭的三名患者中,在两个等位基因的第 14 外显子中鉴定出两个替换:C 到 G 的变化导致 Gln651Glu 替换(先前描述的多态性)以及 T 到 C 的转换导致 Leu660Pro 替换。后者是一个新突变,它为 FnuDII 酶创造了一个限制性位点。在这三个家庭的成员中进行的限制性分析清楚地区分了严重受影响的患者、必然携带者和未受影响的个体。一项群体调查未能在 250 名犹太个体中检测到该突变,但在 300 名阿拉伯人中检测到两名杂合子,表明该群体中 Pro660 等位基因的频率为 0.0033。在三个家庭中的两个家庭中,Pro660 等位基因与因子 XIII a 亚基基因内 5' 短串联重复多态性的等位基因 5 连锁,表明该突变可能至少发生了两次。从患者血小板和单核细胞中分离的 mRNA 获得的 cDNA 在大小上与正常对照相似,表明 Leu660Pro 突变不影响 mRNA 合成。基于因子 XIII a 亚基晶体学研究的计算机建模预测,突变蛋白预计会错误折叠成不稳定或易降解的结构。